RESTEC to organise a stand-alone IPhEB exhibition in Russia from 2018 onwards
Amsterdam, 1st August, 2017: CPhI @ IPhEB Russia – jointly organised by UBM and Restec – which closed its 5th edition on the 30th March 2017, will be discontinued as a CPhI branded event in 2018.
The event, which has grown to 5000 attendees and started in Saint Petersburg in 2011, before moving to the Russian capital in 2015, returns to its original venue and branding next year. Restec will serve its existing customers from 2018 onwards with the stand-alone exhibition in Saint Petersburg – the International Forum on Pharmaceuticals Engineering and Biotechnology (IPhEB).
UBM will concentrate on strengthening its global pharma portfolio growth, with a focus on better serving customer needs. The company is expanding sales in eight other CPhI brands globally, including a new event in the Middle East & Africa for 2018 (taking place in Abu Dhabi) and three editions with more than 40,000 attendees each year (CPhI Worldwide, CPhI India and CPhI China).
Restec will further build the profile of its long-standing IPhEB brand as the premier event for Russia and the CIS economies. The IPhEB will take place in Saint-Petersburg in 2018 and in Moscow in 2019.
- ENDS-
About CPhI
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, North America, Korea, China, India, Japan, Southeast Asia and the Middle East, and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, FDF for finished dosage formulations, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.
For more information visit: www.cphi.com
The UBM annual schedule of Pharmaceutical events includes: CPhI, ICSE, P-MEC, BioPh & Health Ingredients Korea (22-24 August, 2017 at the COEX Hall D – Seoul, Korea); CPhI, ICSE, P-MEC, FDF and InnoPack Worldwide (24-26 October, 2017 at the Messe Frankfurt – Frankfurt, Germany); CPhI & P-MEC India (27-30 November, 2017, BEC and BKC Exhibition and Convention Centres – Mumbai, India), Pharmapack Europe (7-8 February, 2018 at the Paris Expo, Porte de Versailles – Paris, France); CPhI, P-MEC and Innopack South East Asia (27-29 March, 2018 at the Jakarta International Expo – Jakarta, Indonesia); CPhI, ICSE, P-MEC, BioPh and InnoPack Japan (18-20 April, 2018 at the Big Sight Exhibition Centre – Tokyo, Japan); CPhI, ICSE, FDF and InnoPack North America (24-26 April, 2018 at the Pennsylvania Convention Center – Philadelphia, USA); CPhI and P-MEC China (June, 2018 at SNIEC – Shanghai, China); CPhI Middle East & Africa (3-5 September, 2018 at the ADNEC – Abu Dhabi, United Arab Emirates).
About UBM
UBM connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.
About IPhEB
The first International Forum on Pharmaceuticals Engineering and Biotechnology (IPhEB) was held in 2011 in St. Petersburg and organized by RESTEC Exhibition Company. The IPhEB is the only specialised event for API and Finished Formulations serving the Russian market.
The IPhEB is a meeting place for professionals from across the entire Russian pharmaceutical industry and features expert opinions, analysis and debates on how to drive forward business in the region.
For more information visit: www.en.ipheb.ru
For UBM media enquiries, please contact:
Alex Heeley or Alex Allsop
De Facto Communications
T: +44 (0) 203 735 8168
E: a.heeley@defacto.com / a.allsop@defacto.com
